Evidence mapPaperPMID 42093616Full record

ArticleACS applied materials & interfaces2026

Advancing Biomaterials Evaluation: A Human Quadruple Bone Cell Culture Reveals Molybdenum-Driven Pro-Osteogenic and Anti-osteoclastogenic Responses.

Katharina Wirsig, Anne Bernhardt

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Katharina WirsigCentre for Translational Bone, Joint- and Soft Tissue Research, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD University of Technology, Fetscherstraße 74, 01307 Dresden, Germany.ORCID 0009-0003-0099-528X
Anne BernhardtCentre for Translational Bone, Joint- and Soft Tissue Research, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD University of Technology, Fetscherstraße 74, 01307 Dresden, Germany.ORCID 0000-0002-1903-1929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of bone-related diseases and the desire to improve patient outcomes are driving research into bone replacement materials that overcome the limits of current bone substitutes. Molybdenum (Mo) is a promising candidate as an implant and degradable bone replacement material because it combines three key properties: mechanical strength, biocompatibility, and resorbability. However, little is known about the cellular mechanisms induced by Mo on bone regeneration. This study exposed a complex in vitro bone model as quadruple culture with primary human osteoblasts, osteocytes, osteoclasts, and endothelial cells, to Mo powder extracts to understand cell-material interactions in a multicellular system. Extracts with a final concentration of 1 mM Mo in quadruple cultures induced osteogenic differentiation by stimulation of

Indexed as

Biocompatible MaterialsMolybdenumOsteoclastsOsteogenesisCell DifferentiationCells, CulturedHumansHuman Umbilical Vein Endothelial CellsOsteoblastsOsteocytesBiocompatible MaterialsMolybdenumbiomaterialbonecoculturemolybdenumosteoblastosteoclastosteocyte

Identifiers

PMID42093616
PMCPMC13195570

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.